Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 89 entries
Sorted by: Best Match Show Resources per page
Repetitive head impact exposure and later-life plasma total tau in former National Football League players.

Alzheimer's & dementia (Amsterdam, Netherlands)

Alosco ML, Tripodis Y, Jarnagin J, Baugh CM, Martin B, Chaisson CE, Estochen N, Song L, Cantu RC, Jeromin A, Stern RA.
PMID: 28229128
Alzheimers Dement (Amst). 2016 Dec 10;7:33-40. doi: 10.1016/j.dadm.2016.11.003. eCollection 2017.

INTRODUCTION: Blood protein analysis of total tau (t-tau) may be a practical screening biomarker for chronic traumatic encephalopathy (CTE), a neurodegenerative tauopathy associated with repetitive head impact (RHI) exposure. We examined plasma t-tau in symptomatic former National Football League...

Cite
Alosco ML, Tripodis Y, Jarnagin J, et al. Repetitive head impact exposure and later-life plasma total tau in former National Football League players. Alzheimers Dement (Amst). 2016;7:33-40doi: 10.1016/j.dadm.2016.11.003.
Alosco, M. L., Tripodis, Y., Jarnagin, J., Baugh, C. M., Martin, B., Chaisson, C. E., Estochen, N., Song, L., Cantu, R. C., Jeromin, A., & Stern, R. A. (2017). Repetitive head impact exposure and later-life plasma total tau in former National Football League players. Alzheimer's & dementia (Amsterdam, Netherlands), 733-40. https://doi.org/10.1016/j.dadm.2016.11.003
Alosco, Michael L, et al. "Repetitive head impact exposure and later-life plasma total tau in former National Football League players." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 7 (2017): 33-40. doi: https://doi.org/10.1016/j.dadm.2016.11.003
Alosco ML, Tripodis Y, Jarnagin J, Baugh CM, Martin B, Chaisson CE, Estochen N, Song L, Cantu RC, Jeromin A, Stern RA. Repetitive head impact exposure and later-life plasma total tau in former National Football League players. Alzheimers Dement (Amst). 2016 Dec 10;7:33-40. doi: 10.1016/j.dadm.2016.11.003. eCollection 2017. PMID: 28229128; PMCID: PMC5312499.
Copy Download .nbib Format: NLM
Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma.

PloS one

Correa-Gallego C, Maddalo D, Doussot A, Kemeny N, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Betel D, Klimstra D, Jarnagin WR, Ventura A.
PMID: 27685844
PLoS One. 2016 Sep 29;11(9):e0163699. doi: 10.1371/journal.pone.0163699. eCollection 2016.

BACKGROUND: MicroRNAs (miRNAs) are potential biomarkers in various malignancies. We aim to characterize miRNA expression in intrahepatic cholangiocarcinoma (ICC) and identify circulating plasma miRNAs with potential diagnostic and prognostic utility.METHODS: Using deep-sequencing techniques, miRNA expression between tumor samples and...

Cite
Correa-Gallego C, Maddalo D, Doussot A, et al. Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma. PLoS One. 2016;11(9):e0163699doi: 10.1371/journal.pone.0163699.
Correa-Gallego, C., Maddalo, D., Doussot, A., Kemeny, N., Kingham, T. P., Allen, P. J., D'Angelica, M. I., DeMatteo, R. P., Betel, D., Klimstra, D., Jarnagin, W. R., & Ventura, A. (2016). Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma. PloS one, 11(9), e0163699. https://doi.org/10.1371/journal.pone.0163699
Correa-Gallego, Camilo, et al. "Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma." PloS one vol. 11,9 (2016): e0163699. doi: https://doi.org/10.1371/journal.pone.0163699
Correa-Gallego C, Maddalo D, Doussot A, Kemeny N, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Betel D, Klimstra D, Jarnagin WR, Ventura A. Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma. PLoS One. 2016 Sep 29;11(9):e0163699. doi: 10.1371/journal.pone.0163699. eCollection 2016. PMID: 27685844; PMCID: PMC5042503.
Copy Download .nbib Format: NLM
Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram.

Annals of oncology : official journal of the European Society for Medical Oncology

Groot Koerkamp B, Wiggers JK, Gonen M, Doussot A, Allen PJ, Besselink MG, Blumgart LH, Busch OR, D'Angelica MI, DeMatteo RP, Gouma DJ, Kingham TP, van Gulik TM, Jarnagin WR.
PMID: 26920702
Ann Oncol. 2016 Apr;27(4):753. doi: 10.1093/annonc/mdw063. Epub 2016 Feb 25.

No abstract available.

Cite
Groot Koerkamp B, Wiggers JK, Gonen M, et al. Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram. Ann Oncol. 2016;27(4):753doi: 10.1093/annonc/mdw063.
Groot Koerkamp, B., Wiggers, J. K., Gonen, M., Doussot, A., Allen, P. J., Besselink, M. G., Blumgart, L. H., Busch, O. R., D'Angelica, M. I., DeMatteo, R. P., Gouma, D. J., Kingham, T. P., van Gulik, T. M., & Jarnagin, W. R. (2016). Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram. Annals of oncology : official journal of the European Society for Medical Oncology, 27(4), 753. https://doi.org/10.1093/annonc/mdw063
Groot Koerkamp, B, et al. "Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram." Annals of oncology : official journal of the European Society for Medical Oncology vol. 27,4 (2016): 753. doi: https://doi.org/10.1093/annonc/mdw063
Groot Koerkamp B, Wiggers JK, Gonen M, Doussot A, Allen PJ, Besselink MG, Blumgart LH, Busch OR, D'Angelica MI, DeMatteo RP, Gouma DJ, Kingham TP, van Gulik TM, Jarnagin WR. Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram. Ann Oncol. 2016 Apr;27(4):753. doi: 10.1093/annonc/mdw063. Epub 2016 Feb 25. PMID: 26920702; PMCID: PMC4803457.
Copy Download .nbib Format: NLM
Intragalactic Communication.

Science (New York, N.Y.)

Jarnagin WS.
PMID: 17773938
Science. 1960 Apr 22;131(3408):1262-3. doi: 10.1126/science.131.3408.1262.

No abstract available.

Cite
Jarnagin WS. Intragalactic Communication. Science. 1960;131(3408):1262-3doi: 10.1126/science.131.3408.1262.
Jarnagin, W. S. (1960). Intragalactic Communication. Science (New York, N.Y.), 131(3408), 1262-3. https://doi.org/10.1126/science.131.3408.1262
Jarnagin, W S. "Intragalactic Communication." Science (New York, N.Y.) vol. 131,3408 (1960): 1262-3. doi: https://doi.org/10.1126/science.131.3408.1262
Jarnagin WS. Intragalactic Communication. Science. 1960 Apr 22;131(3408):1262-3. doi: 10.1126/science.131.3408.1262. PMID: 17773938.
Copy Download .nbib Format: NLM
Hilar cholangiocarcinoma: diagnosis and staging.

HPB : the official journal of the International Hepato Pancreato Biliary Association

Jarnagin W, Winston C.
PMID: 18333200
HPB (Oxford). 2005;7(4):244-51. doi: 10.1080/13651820500372533.

Cancer arising from the proximal biliary tree, or hilar cholangiocarcinoma, remains a difficult clinical problem. Significant experience with these uncommon tumors has been limited to a small number of centers, which has greatly hindered progress. Complete resection of hilar...

Cite
Jarnagin W, Winston C. Hilar cholangiocarcinoma: diagnosis and staging. HPB (Oxford). 2005;7(4):244-51doi: 10.1080/13651820500372533.
Jarnagin, W., & Winston, C. (2005). Hilar cholangiocarcinoma: diagnosis and staging. HPB : the official journal of the International Hepato Pancreato Biliary Association, 7(4), 244-51. https://doi.org/10.1080/13651820500372533
Jarnagin, William, and Winston, Corinne. "Hilar cholangiocarcinoma: diagnosis and staging." HPB : the official journal of the International Hepato Pancreato Biliary Association vol. 7,4 (2005): 244-51. doi: https://doi.org/10.1080/13651820500372533
Jarnagin W, Winston C. Hilar cholangiocarcinoma: diagnosis and staging. HPB (Oxford). 2005;7(4):244-51. doi: 10.1080/13651820500372533. PMID: 18333200; PMCID: PMC2043098.
Copy Download .nbib Format: NLM
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors.

Annals of surgery

Pulvirenti A, Javed AA, Landoni L, Jamieson NB, Chou JF, Miotto M, He J, Gonen M, Pea A, Tang LH, Nessi C, Cingarlini S, D'Angelica MI, Gill AJ, Kingham TP, Scarpa A, Weiss MJ, Balachandran VP, Samra JS, Cameron JL, Jarnagin WR, Salvia R, Wolfgang CL, Allen PJ, Bassiy C.
PMID: 31567347
Ann Surg. 2021 Dec 01;274(6):1051-1057. doi: 10.1097/SLA.0000000000003579.

OBJECTIVE: To develop a nomogram estimating the probability of recurrence free at 5 years after resection for localized grade 1 (G1)/ grade 2 (G2) pancreatic neuroendocrine tumors (PanNETs).BACKGROUND: Among patients undergoing resection of PanNETs, approximately 17% experience recurrence. It...

Cite
Pulvirenti A, Javed AA, Landoni L, et al. Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors. Ann Surg. 2021;274(6):1051-1057doi: 10.1097/SLA.0000000000003579.
Pulvirenti, A., Javed, A. A., Landoni, L., Jamieson, N. B., Chou, J. F., Miotto, M., He, J., Gonen, M., Pea, A., Tang, L. H., Nessi, C., Cingarlini, S., D'Angelica, M. I., Gill, A. J., Kingham, T. P., Scarpa, A., Weiss, M. J., Balachandran, V. P., Samra, J. S., Cameron, J. L., Jarnagin, W. R., Salvia, R., Wolfgang, C. L., Allen, P. J., & Bassiy, C. (2021). Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors. Annals of surgery, 274(6), 1051-1057. https://doi.org/10.1097/SLA.0000000000003579
Pulvirenti, Alessandra, et al. "Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors." Annals of surgery vol. 274,6 (2021): 1051-1057. doi: https://doi.org/10.1097/SLA.0000000000003579
Pulvirenti A, Javed AA, Landoni L, Jamieson NB, Chou JF, Miotto M, He J, Gonen M, Pea A, Tang LH, Nessi C, Cingarlini S, D'Angelica MI, Gill AJ, Kingham TP, Scarpa A, Weiss MJ, Balachandran VP, Samra JS, Cameron JL, Jarnagin WR, Salvia R, Wolfgang CL, Allen PJ, Bassiy C. Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors. Ann Surg. 2021 Dec 01;274(6):1051-1057. doi: 10.1097/SLA.0000000000003579. PMID: 31567347; PMCID: PMC8557638.
Copy Download .nbib Format: NLM
Improving actual survival after hepatectomy for intrahepatic cholangiocarcinoma-still a long way to go.

Hepatobiliary surgery and nutrition

Doussot A, Jarnagin WR, Azoulay D, Heyd B.
PMID: 31098368
Hepatobiliary Surg Nutr. 2019 Apr;8(2):161-163. doi: 10.21037/hbsn.2018.11.21.

No abstract available.

Cite
Doussot A, Jarnagin WR, Azoulay D, et al. Improving actual survival after hepatectomy for intrahepatic cholangiocarcinoma-still a long way to go. Hepatobiliary Surg Nutr. 2019;8(2):161-163doi: 10.21037/hbsn.2018.11.21.
Doussot, A., Jarnagin, W. R., Azoulay, D., & Heyd, B. (2019). Improving actual survival after hepatectomy for intrahepatic cholangiocarcinoma-still a long way to go. Hepatobiliary surgery and nutrition, 8(2), 161-163. https://doi.org/10.21037/hbsn.2018.11.21
Doussot, Alexandre, et al. "Improving actual survival after hepatectomy for intrahepatic cholangiocarcinoma-still a long way to go." Hepatobiliary surgery and nutrition vol. 8,2 (2019): 161-163. doi: https://doi.org/10.21037/hbsn.2018.11.21
Doussot A, Jarnagin WR, Azoulay D, Heyd B. Improving actual survival after hepatectomy for intrahepatic cholangiocarcinoma-still a long way to go. Hepatobiliary Surg Nutr. 2019 Apr;8(2):161-163. doi: 10.21037/hbsn.2018.11.21. PMID: 31098368; PMCID: PMC6503243.
Copy Download .nbib Format: NLM
Safety and Efficacy of Hepatic Artery Embolization in Treating Solitary Fibrous Tumor Metastatic to the Liver.

Sarcoma

Velayati S, Erinjeri JP, Brody LA, Ziv E, Boas FE, Brown KT, Covey AM, Getrajdman GI, Solomon SB, Kingham PT, Tap WD, Jarnagin WR, Yarmohammadi H.
PMID: 31565028
Sarcoma. 2019 Sep 03;2019:3060658. doi: 10.1155/2019/3060658. eCollection 2019.

The aim of this study was to evaluate safety and survival following hepatic artery embolization (HAE) for metastatic solitary fibrous tumor (SFT) in the liver. All patients with SFT metastatic to liver treated with HAE were retrospectively analyzed. Tumor...

Cite
Velayati S, Erinjeri JP, Brody LA, et al. Safety and Efficacy of Hepatic Artery Embolization in Treating Solitary Fibrous Tumor Metastatic to the Liver. Sarcoma. 2019;2019:3060658doi: 10.1155/2019/3060658.
Velayati, S., Erinjeri, J. P., Brody, L. A., Ziv, E., Boas, F. E., Brown, K. T., Covey, A. M., Getrajdman, G. I., Solomon, S. B., Kingham, P. T., Tap, W. D., Jarnagin, W. R., & Yarmohammadi, H. (2019). Safety and Efficacy of Hepatic Artery Embolization in Treating Solitary Fibrous Tumor Metastatic to the Liver. Sarcoma, 20193060658. https://doi.org/10.1155/2019/3060658
Velayati, Sara, et al. "Safety and Efficacy of Hepatic Artery Embolization in Treating Solitary Fibrous Tumor Metastatic to the Liver." Sarcoma vol. 2019 (2019): 3060658. doi: https://doi.org/10.1155/2019/3060658
Velayati S, Erinjeri JP, Brody LA, Ziv E, Boas FE, Brown KT, Covey AM, Getrajdman GI, Solomon SB, Kingham PT, Tap WD, Jarnagin WR, Yarmohammadi H. Safety and Efficacy of Hepatic Artery Embolization in Treating Solitary Fibrous Tumor Metastatic to the Liver. Sarcoma. 2019 Sep 03;2019:3060658. doi: 10.1155/2019/3060658. eCollection 2019. PMID: 31565028; PMCID: PMC6745165.
Copy Download .nbib Format: NLM
Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms.

Journal of medical imaging (Bellingham, Wash.)

Harrington KA, Williams TL, Lawrence SA, Chakraborty J, Al Efishat MA, Attiyeh MA, Askan G, Chou Y, Pulvirenti A, McIntyre CA, Gonen M, Basturk O, Balachandran VP, Kingham TP, D'Angelica MI, Jarnagin WR, Drebin JA, Do RK, Allen PJ, Simpson AL.
PMID: 32613028
J Med Imaging (Bellingham). 2020 May;7(3):031507. doi: 10.1117/1.JMI.7.3.031507. Epub 2020 Jun 25.

No abstract available.

Cite
Harrington KA, Williams TL, Lawrence SA, et al. Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms. J Med Imaging (Bellingham). 2020;7(3):031507doi: 10.1117/1.JMI.7.3.031507.
Harrington, K. A., Williams, T. L., Lawrence, S. A., Chakraborty, J., Al Efishat, M. A., Attiyeh, M. A., Askan, G., Chou, Y., Pulvirenti, A., McIntyre, C. A., Gonen, M., Basturk, O., Balachandran, V. P., Kingham, T. P., D'Angelica, M. I., Jarnagin, W. R., Drebin, J. A., Do, R. K., Allen, P. J., & Simpson, A. L. (2020). Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms. Journal of medical imaging (Bellingham, Wash.), 7(3), 031507. https://doi.org/10.1117/1.JMI.7.3.031507
Harrington, Kate A, et al. "Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms." Journal of medical imaging (Bellingham, Wash.) vol. 7,3 (2020): 031507. doi: https://doi.org/10.1117/1.JMI.7.3.031507
Harrington KA, Williams TL, Lawrence SA, Chakraborty J, Al Efishat MA, Attiyeh MA, Askan G, Chou Y, Pulvirenti A, McIntyre CA, Gonen M, Basturk O, Balachandran VP, Kingham TP, D'Angelica MI, Jarnagin WR, Drebin JA, Do RK, Allen PJ, Simpson AL. Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms. J Med Imaging (Bellingham). 2020 May;7(3):031507. doi: 10.1117/1.JMI.7.3.031507. Epub 2020 Jun 25. PMID: 32613028; PMCID: PMC7315109.
Copy Download .nbib Format: NLM
Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection.

Clinical cancer research : an official journal of the American Association for Cancer Research

Jolissaint JS, Soares KC, Seier KP, Kundra R, Gönen M, Shin PJ, Boerner T, Sigel C, Madupuri R, Vakiani E, Cercek A, Harding JJ, Kemeny NE, Connell LC, Balachandran VP, D'Angelica MI, Drebin JA, Kingham TP, Wei AC, Jarnagin WR.
PMID: 33963001
Clin Cancer Res. 2021 Jul 15;27(14):4101-4108. doi: 10.1158/1078-0432.CCR-21-0412. Epub 2021 May 07.

PURPOSE: Lymph node metastasis (LNM) drastically reduces survival after resection of intrahepatic cholangiocarcinoma (IHC). Optimal treatment is ill defined, and it is unclear whether tumor mutational profiling can support treatment decisions.EXPERIMENTAL DESIGN: Patients with liver-limited IHC with or without...

Cite
Jolissaint JS, Soares KC, Seier KP, et al. Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection. Clin Cancer Res. 2021;27(14):4101-4108doi: 10.1158/1078-0432.CCR-21-0412.
Jolissaint, J. S., Soares, K. C., Seier, K. P., Kundra, R., Gönen, M., Shin, P. J., Boerner, T., Sigel, C., Madupuri, R., Vakiani, E., Cercek, A., Harding, J. J., Kemeny, N. E., Connell, L. C., Balachandran, V. P., D'Angelica, M. I., Drebin, J. A., Kingham, T. P., Wei, A. C., & Jarnagin, W. R. (2021). Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(14), 4101-4108. https://doi.org/10.1158/1078-0432.CCR-21-0412
Jolissaint, Joshua S, et al. "Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,14 (2021): 4101-4108. doi: https://doi.org/10.1158/1078-0432.CCR-21-0412
Jolissaint JS, Soares KC, Seier KP, Kundra R, Gönen M, Shin PJ, Boerner T, Sigel C, Madupuri R, Vakiani E, Cercek A, Harding JJ, Kemeny NE, Connell LC, Balachandran VP, D'Angelica MI, Drebin JA, Kingham TP, Wei AC, Jarnagin WR. Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection. Clin Cancer Res. 2021 Jul 15;27(14):4101-4108. doi: 10.1158/1078-0432.CCR-21-0412. Epub 2021 May 07. PMID: 33963001; PMCID: PMC8282702.
Copy Download .nbib Format: NLM
Genomic Stratification of Resectable Colorectal Liver Metastasis Patients and Implications for Adjuvant Therapy and Survival.

Annals of surgery

Ecker BL, Shin P, Saadat LV, Court CM, Balachandran VP, Chandwani R, Drebin JA, Jarnagin WR, Kingham TP, Soares KC, Vakiani E, Wei AC, Kemeny NE, Smith JJ, Gonen M, D'Angelica MI.
PMID: 34793355
Ann Surg. 2021 Nov 18; doi: 10.1097/SLA.0000000000005315. Epub 2021 Nov 18.

OBJECTIVE: To determine whether genomic risk groups identified by somatic mutation testing of colorectal liver metastasis (CRLM) can be used for "molecularly-guided" selection for adjuvant systemic chemotherapy and hepatic artery infusion of FUDR (SYS+HAI-FUDR).BACKGROUND: Several genomic biomarkers have been...

Cite
Ecker BL, Shin P, Saadat LV, et al. Genomic Stratification of Resectable Colorectal Liver Metastasis Patients and Implications for Adjuvant Therapy and Survival. Ann Surg. 2021;doi: 10.1097/SLA.0000000000005315.
Ecker, B. L., Shin, P., Saadat, L. V., Court, C. M., Balachandran, V. P., Chandwani, R., Drebin, J. A., Jarnagin, W. R., Kingham, T. P., Soares, K. C., Vakiani, E., Wei, A. C., Kemeny, N. E., Smith, J. J., Gonen, M., & D'Angelica, M. I. (2021). Genomic Stratification of Resectable Colorectal Liver Metastasis Patients and Implications for Adjuvant Therapy and Survival. Annals of surgery, . https://doi.org/10.1097/SLA.0000000000005315
Ecker, Brett L, et al. "Genomic Stratification of Resectable Colorectal Liver Metastasis Patients and Implications for Adjuvant Therapy and Survival." Annals of surgery vol. (2021). doi: https://doi.org/10.1097/SLA.0000000000005315
Ecker BL, Shin P, Saadat LV, Court CM, Balachandran VP, Chandwani R, Drebin JA, Jarnagin WR, Kingham TP, Soares KC, Vakiani E, Wei AC, Kemeny NE, Smith JJ, Gonen M, D'Angelica MI. Genomic Stratification of Resectable Colorectal Liver Metastasis Patients and Implications for Adjuvant Therapy and Survival. Ann Surg. 2021 Nov 18; doi: 10.1097/SLA.0000000000005315. Epub 2021 Nov 18. PMID: 34793355.
Copy Download .nbib Format: NLM
ASO Visual Abstract: Timing of Primary Tumor Resection in Synchronous Metastatic Colon Cancer Patients Undergoing Hepatic Arterial Infusion Pump Placement.

Annals of surgical oncology

Verheij FS, Soares KC, Beets GL, Kok NFM, Yuval JB, Kemeny NE, Kingham TP, Jarnagin WR, D'Angelica MI, Garcia-Aguilar J.
PMID: 34993658
Ann Surg Oncol. 2022 Jan 07; doi: 10.1245/s10434-021-11106-7. Epub 2022 Jan 07.

No abstract available.

Cite
Verheij FS, Soares KC, Beets GL, et al. ASO Visual Abstract: Timing of Primary Tumor Resection in Synchronous Metastatic Colon Cancer Patients Undergoing Hepatic Arterial Infusion Pump Placement. Ann Surg Oncol. 2022;doi: 10.1245/s10434-021-11106-7.
Verheij, F. S., Soares, K. C., Beets, G. L., Kok, N. F. M., Yuval, J. B., Kemeny, N. E., Kingham, T. P., Jarnagin, W. R., D'Angelica, M. I., & Garcia-Aguilar, J. (2022). ASO Visual Abstract: Timing of Primary Tumor Resection in Synchronous Metastatic Colon Cancer Patients Undergoing Hepatic Arterial Infusion Pump Placement. Annals of surgical oncology, . https://doi.org/10.1245/s10434-021-11106-7
Verheij, Floris S, et al. "ASO Visual Abstract: Timing of Primary Tumor Resection in Synchronous Metastatic Colon Cancer Patients Undergoing Hepatic Arterial Infusion Pump Placement." Annals of surgical oncology vol. (2022). doi: https://doi.org/10.1245/s10434-021-11106-7
Verheij FS, Soares KC, Beets GL, Kok NFM, Yuval JB, Kemeny NE, Kingham TP, Jarnagin WR, D'Angelica MI, Garcia-Aguilar J. ASO Visual Abstract: Timing of Primary Tumor Resection in Synchronous Metastatic Colon Cancer Patients Undergoing Hepatic Arterial Infusion Pump Placement. Ann Surg Oncol. 2022 Jan 07; doi: 10.1245/s10434-021-11106-7. Epub 2022 Jan 07. PMID: 34993658.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 89 entries